Senate Resolution 42 formally proclaims May 2025 as Amyotrophic Lateral Sclerosis (ALS) Awareness Month in California and urges public support for ALS research, increased funding, and solidarity with people affected by the disease. The text collects factual findings about ALS — its progressive, fatal course, the typical two-to-five year survival after diagnosis, the central role of clinical trials and assistive technology, and higher incidence among people who served in the military.
The resolution is ceremonial: it does not appropriate funds or create new programs. Its practical value lies in signaling legislative attention, providing a lever for advocacy and fundraising, and calling out specific priorities (research acceleration, access to durable medical equipment and communication technologies, and clinical-trial participation).
The Secretary of the Senate is directed to transmit copies of the resolution for distribution, enabling stakeholders to cite the Legislature’s recognition in outreach and grant applications.
At a Glance
What It Does
Declares May 2025 as ALS Awareness Month in California, recites a series of findings about the disease, and urges citizens to support research, funding, and those affected. It also directs the Senate Secretary to transmit copies of the resolution for distribution.
Who It Affects
Directly relevant to people living with ALS and their caregivers, research organizations and clinical-trial sites, veterans’ advocacy groups given the noted higher risk among veterans, and nonprofit funders such as the ALS Association.
Why It Matters
Although nonbinding, the resolution amplifies advocacy efforts, can be used by nonprofits and clinics to boost recruitment and fundraising, and signals a legislative recognition of veteran-linked disease risk that advocacy groups may use to press for targeted programs or funding.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SR 42 is a classic legislative recognition: a preamble of “whereas” clauses followed by a short set of “resolved” statements. The preamble summarizes current facts as the Legislature sees them — ALS is progressive and fatal, survival after diagnosis is typically measured in years, cause and cure remain unknown, clinical trials and assistive technologies are essential, and people with military service appear at higher risk.
The text cites the ALS Association’s global philanthropic role and specific funding totals to underline the scale of private-sector investment in research.
The operative text accomplishes three things. First, it proclaims May 2025 as ALS Awareness Month in California.
Second, it issues a public call to action asking Americans to support ALS research, advocate for more funding, and stand with those affected. Third, it instructs the Secretary of the Senate to transmit copies of the resolution to the author for distribution.
The resolution does not establish any state programs, budgetary commitments, regulatory changes, or enforcement mechanisms.Practically, the resolution creates a legislative imprimatur that stakeholders can cite. Nonprofits and clinical-research centers can use the proclamation in promotional materials, fundraising appeals, and recruitment for trials.
Veteran and disability advocacy groups may leverage the Legislature’s explicit recognition of elevated veteran risk to justify outreach or lobbying for services. Conversely, because the document contains no funding language, it leaves unresolved how the identified needs — equipment access, therapies, clinical-trial capacity — would be financed or implemented at the state level.
The Five Things You Need to Know
SR 42 is a California Senate resolution that proclaims May 2025 as Amyotrophic Lateral Sclerosis Awareness Month.
The preamble explicitly states that people who have served in the military are more likely to develop ALS and to die from it than those without military service.
The resolution cites the ALS Association’s philanthropic contribution of more than $154,000,000 supporting over 550 projects across the United States and 18 other countries.
The operative language urges support for research, increased funding, clinical trials, and access to durable medical equipment and communication technologies but authorizes no spending or new programs.
The Secretary of the Senate is directed to transmit copies of the resolution to the author for appropriate distribution, enabling stakeholders to obtain an official copy for advocacy and outreach.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Findings about ALS and reasons for recognition
This section gathers factual statements the Senate relied on: ALS is a progressive, fatal neurodegenerative disease; average survival after diagnosis is two to five years; clinical trials and assistive technologies matter; and veterans face higher risk. The preamble also highlights the ALS Association’s research funding. These findings create the factual predicate that justifies the proclamation and provide ready-made language stakeholders can quote in grant applications or public communications.
Proclamation of ALS Awareness Month
The resolution formally designates May 2025 as Amyotrophic Lateral Sclerosis Awareness Month in California. As a legislative proclamation, this is declaratory and ceremonial: it recognizes an issue but does not establish new legal duties, programs, or budget lines. The practical effect is reputational — offering recognition that entities can use in outreach and awareness campaigns.
Call to action for research, funding, and solidarity
The text calls upon all Americans to support ALS research, advocate for increased funding, and stand in solidarity with those affected. The clause functions as a policy signal rather than a mandate: it signals legislative priorities and may be used by advocacy groups to press for legislative or executive action, but it imposes no legal obligations on state agencies, private funders, or health providers.
Administrative transmittal
The resolution directs the Secretary of the Senate to transmit copies of the resolution to the author for distribution. This procedural step ensures stakeholders can obtain certified copies for use in official communications. It also commits minor staff time to distribution and record-keeping, but creates no ongoing administrative program.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- People living with ALS and their families — the proclamation raises public awareness and can help mobilize community support, fundraising, and visibility for their access needs.
- The ALS Association and other nonprofits — the Legislature’s citation of the organization’s funding and the formal month designation provide a legislative endorsement useful in outreach, donor cultivation, and event promotion.
- Clinical researchers and trial sites — heightened awareness can increase volunteer recruitment for trials and public interest in new therapies.
- Veterans’ advocacy groups — the resolution’s explicit finding about elevated veteran risk gives these groups a cited legislative fact to support targeted outreach and service claims.
- Disability service providers and assistive-technology vendors — the emphasis on durable medical equipment and communication technologies can justify local initiatives and partnerships aimed at improving access.
Who Bears the Cost
- California Senate administration — minor administrative and staff time to prepare and transmit certified copies and to record the resolution.
- Nonprofit organizations — while they benefit from the recognition, they may face increased expectations to coordinate events and campaigns without additional funding.
- Clinical-trial sites and researchers — increased recruitment demand may strain staff and resources if not accompanied by additional funding or infrastructure.
- Veterans’ service offices — the legislative spotlight may create pressure to respond with programs or outreach despite no new state funding.
- State agencies (indirectly) — agencies fielding requests for programmatic responses may need to allocate time to stakeholder engagement even though the resolution creates no mandate or appropriation.
Key Issues
The Core Tension
The central dilemma is recognition versus remedy: the Legislature can and does signal priorities through a resolution, but that symbolic action risks creating public expectation for concrete change without providing the funding, programs, or authority needed to deliver it — shifting the burden to nonprofits, researchers, and overstretched agencies to convert awareness into measurable improvements.
SR 42 is strictly declaratory. It lists problems — gaps in treatments, equipment needs, and higher veteran risk — and urges action, but it contains no authorization of expenditures, no directives to state agencies to change eligibility or service delivery, and no metrics to measure whether awareness activities improve outcomes.
That gap is the practical limit of the resolution’s power: recognition can amplify advocacy and fundraising, but it cannot by itself move state budgets or regulatory frameworks.
The resolution also bundles different policy issues without distinguishing how to address them. Calling for “increased funding” and improved access to assistive technologies does not specify funding sources, program models, or accountability mechanisms; veteran risk is highlighted but no veteran-specific monitoring, research priorities, or outreach programs are established.
Implementation therefore depends entirely on follow-up from advocacy groups, agencies, or future legislation. Finally, reliance on nonprofit funding (the ALS Association’s cited contributions) raises a governance question: public recognition can increase dependence on philanthropy rather than driving sustainable public investment in research, equipment access, or long-term care.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.